Cited by 690Lipid metabolism and disordersLiver Disease Diagnosis and TreatmentDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index.

Overproduction of large VLDL particles is driven by increased liver fat content in man

Open access

Adiels, M., Taskinen, M.-R., Packard, C., Caslake, M. J., Soro-Paavonen, A., Westerbacka, J., Vehkavaara, S., Häkkinen, A., Olofsson, S.-O., Yki-Järvinen, H., Borén, J.·2006·Diabetologia

DOI 10.1007/s00125-005-0125-z

Open this paper in CoChat — free account Open PDF

Abstract

Aims/hypothesis We determined whether hepatic fat content and plasma adiponectin concentration regulate VLDL(1) production.Methods A multicompartment model was used to simultaneously determine the kinetic parameters of triglycerides (TGs) and apolipoprotein B (ApoB) in VLDL(1) and VLDL(2) after a bolus of [(2)H(3)]leucine and [(2)H(5)]glycerol in ten men with type 2 diabetes and in 18 non-diabetic men. Liver fat content was determined by proton spectroscopy and intra-abdominal fat content by MRI.Results Univariate regression analysis showed that liver fat content, intra-abdominal fat volume, plasma glucose, insulin and HOMA-IR (homeostasis model assessment of insulin resistance) correlated with VLDL(1) TG and ApoB production. However, only liver fat and plasma glucose were significant in multiple regression models, emphasising the critical role of substrate fluxes and lipid availability in the liver as the driving force for overproduction of VLDL(1) in subjects with type 2 diabetes. Despite negative correlations with fasting TG levels, liver fat content, and VLDL(1) TG and ApoB pool sizes, adiponectin was not linked to VLDL(1) TG or ApoB production and thus was not a predictor of VLDL(1) production. However, adiponectin correlated negatively with the removal rates of VLDL(1) TG and ApoB.Conclusions/interpretation We propose that the metabolic effect of insulin resistance, partly mediated by depressed plasma adiponectin levels, increases fatty acid flux from adipose tissue to the liver and induces the accumulation of fat in the liver. Elevated plasma glucose can further increase hepatic fat content through multiple pathways, resulting in overproduction of VLDL(1) particles and leading to the characteristic dyslipidaemia associated with type 2 diabetes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/s00125-005-0125-z

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Use and Abuse of HOMA Modeling
Wallace, T. M., Levy, J. C., & Matthews, D. R. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1487 · Cited by 5,114
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase
Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238
Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Cloning of adiponectin receptors that mediate antidiabetic metabolic effects
Yamauchi, T., Kamon, J., Ito, Y., Tsuchida, A., Yokomizo, T., Kita, S., Sugiyama, T., Miyagishi, M., Hara, K., Tsunoda, M., et al. (2003) · Nature · doi:10.1038/nature01705 · Cited by 3,176
Nonalcoholic Fatty Liver Disease
Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Bugianesi, E., Lenzi, M., McCullough, A. J., Natale, S., Forlani, G., & Melchionda, N. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1844 · Cited by 2,581
Molecular mediators of hepatic steatosis and liver injury
Browning, J. D., & Horton, J. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422422 · Cited by 1,772
Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728
Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex
Cnop, M., Havel, P. J., Utzschneider, K. M., Carr, D. B., Sinha, M. K., Boyko, E. J., Retzlaff, B. M., Knopp, R. H., Brunzell, J. D., & Kahn, S. E. (2003) · Diabetologia · doi:10.1007/s00125-003-1074-z · Cited by 1,483
Banting Lecture 2001
McGarry, J. D. (2002) · Diabetes · doi:10.2337/diabetes.51.1.7 · Cited by 1,435
Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes
Lewis, G. F., Carpentier, A. C., Adeli, K., & Giacca, A. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.2.0461 · Cited by 1,370

Show all 53 references

Research works printed but not linked: 2

World Health Organization (1999) Report of a WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Department of Noncommunicable Disease Surveillance. World Health Organization, Geneva
Lindgren F, Jensen L (1972) The isolation and quantitative analysis of serum lipoproteins. In: Nelson GJ (ed.) Blood lipids and lipoproteins: quantification, composition and metabolism. Wiley, Livermore, CA, pp 182–217

Sorted by citations

Items 401–500 of 689

Liver metabolism in human MASLD: A review of recent advancements using human tissue metabolomics
Flam, E. L., Haas, J. T., & Staels, B. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.119054 · Cited by 17
CIRCULATING IGFBP-2 LEVELS ARE INCREMENTALLY LINKED TO CORRELATES OF THE METABOLIC SYNDROME AND INDEPENDENTLY ASSOCIATED WITH VLDL TRIGLYCERIDES
Carter, S., Li, Z., Alméras, N., Tremblay, A., Bergeron, J., Poirier, P., Deshaies, Y., Després, J., & Picard, F. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.07.424 · Cited by 16
The Crude Extract fromPuerariaeFlower Exerts Antiobesity and Antifatty Liver Effects in High-Fat Diet-Induced Obese Mice
Kamiya, T., Sameshima-Kamiya, M., Nagamine, R., Tsubata, M., Ikeguchi, M., Takagaki, K., Shimada, T., & Aburada, M. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/272710 · Cited by 16
[Non-alcoholic fatty liver disease: a new challenge for cardiologists].
Tarquini, R., Lazzeri, C., Boddi, M., Marra, F., Abbate, R., & Gensini, G. F. (2010) · PubMed · Cited by 16
Understanding the Alterations in Lipid Metabolism in NAFLD Progression: Current Trends and Future Directions
Mungamuri, S. K., Sinha, S. N., & Javvadi, Y. (2020) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2020035839 · Cited by 17
Assessment of liver stiffness in subjects affected by familial combined hyperlipidaemia with hepatic steatosis
Riggio, S., Mamone, F., Mandraffino, G., Maimone, S., Alibrandi, A., Manti, L., Saitta, C., Tripodi, P. F., Sardo, M. A., Squadrito, G., et al. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02323.x · Cited by 16
Low normal thyroid function as a determinant of increased large very low density lipoprotein particles
van Tienhoven‐Wind, L. J. N., & Dullaart, R. P. F. (2015) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2015.01.015 · Cited by 15
Lipid disorders in type 2 diabetes
Laakso, M. (2009) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(09)73517-x · Cited by 18
Recent Insights into the Relationship between Inflammatory Liver Diseases and Atherosclerosis
Pürnak, T., Efe, C., Beyazıt, Y., Özaslan, E., Astan, R., Milanlıoğlu, A., Özbalkan, Z., & Rizzo, M. (2011) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e318217f3a0 · Cited by 16
Is the Amount of Coronary Perivascular Fat Related to Atherosclerosis?
Lesná, I. K., Tonar, Z., Malek, I., Malušková, J., Nedorost, L., Pirk, J., Pitha, J. V., Lánská, V., & Poledne, R. (2015) · Physiological Research · doi:10.33549/physiolres.933151 · Cited by 16
Gene Polymorphisms of FABP2, ADIPOQ and ANP and Risk of Hypertriglyceridemia and Metabolic Syndrome in Afro-Caribbeans
Larifla, L., Rambhojan, C., Joannes, M.-O., Maimaitiming-Madani, S., Donnet, J., Marianne-Pépin, T., Chout, R., Roussel, R., & Foucan, L. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163421 · Cited by 14
Multiple voxel 1H MR spectroscopy of phosphorylase-b kinase deficient patients (GSD IXa) showing an accumulation of fat in the liver that resolves with aging
Sijens, P. E., Smit, G., Borgdorff, M. A. J., Kappert, P., & Oudkerk, M. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.06.021 · Cited by 16
The ins and outs of liver fat metabolism: The effect of phenotype and diet on risk of intrahepatic triglyceride accumulation
Smith, K., Dennis, K. M. J. H., & Hodson, L. (2025) · Experimental Physiology · doi:10.1113/ep092001 · Cited by 18
Fructose 1-phosphate, an evolutionary signaling molecule of abundancy
Brouwers, M. C. G. J. (2022) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2022.07.007 · Cited by 14
World Congress on Insulin Resistance, Diabetes, and Cardiovascular Disease
Bloomgarden, Z. T. (2011) · Diabetes Care · doi:10.2337/dc11-1306 · Cited by 15
The Severity of Fatty Liver Disease Relating to Metabolic Abnormalities Independently Predicts Coronary Calcification
Lee, Y., Wu, Y., Liu, C., Hou, C. J., Yeh, H., Tsai, C., Shih, S., & Hung, C. (2011) · Radiology Research and Practice · doi:10.1155/2011/586785 · Cited by 15
Fatty acid and very low density lipoprotein metabolism in obese African American and Caucasian women with type 2 diabetes
Miller, B. V., Patterson, B. W., Okunade, A. L., & Klein, S. (2012) · Journal of Lipid Research · doi:10.1194/jlr.p030593 · Cited by 15
Mathematical modelling of competitive LDL/VLDL binding and uptake by hepatocytes
Pearson, T., Wattis, J. A. D., O’Malley, B., Pickersgill, L., Blackburn, H., Jackson, K. G., & Byrne, H. M. (2008) · Journal of Mathematical Biology · doi:10.1007/s00285-008-0205-z · Cited by 15
Exercise increases myocardial free fatty acid oxidation in subjects with metabolic dysfunction-associated fatty liver disease
Risikesan, J., Heebøll, S., Kumarathas, I., Funck, K. L., Søndergaard, E., Johansen, R. F., Ringgaard, S., Tolbod, L. P., Johannsen, M., Kanstrup, H., et al. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.03.015 · Cited by 14
IL32 downregulation lowers triglycerides and type I collagen in di-lineage human primary liver organoids
Sasidharan, K., Caddeo, A. M., Jamialahmadi, O., Noto, F. R., Tomasi, M., Malvestiti, F., Ciociola, E., Tavaglione, F., Mancina, R. M., Cherubini, A., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101352 · Cited by 20
Self-citation
Semaglutide Treatment Effects on Liver Fat Content in Obese Subjects with Metabolic-Associated Steatotic Liver Disease (MASLD)
Dusilová, T., Kovář, J., Laňková, I., Thieme, L., Hubáčková, M., Šedivý, P., Pajuelo, D., Burian, M., Dezortová, M., Miklánková, D., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13206100 · Cited by 15
Mitochondria at the Crossroads: Linking the Mediterranean Diet to Metabolic Health and Non-Pharmacological Approaches to NAFLD
Mercurio, G., Giacco, A., Scopigno, N., Vigliotti, M., Goglia, F., Cioffi, F., & Silvestri, E. (2025) · Nutrients · doi:10.3390/nu17071214 · Cited by 16
The effects of different doses of exercise on pancreatic β-cell function in patients with newly diagnosed type 2 diabetes: study protocol for and rationale behind the “DOSE-EX” multi-arm parallel-group randomised clinical trial
Lyngbæk, M. P. P., Legaard, G. E., Bennetsen, S. L., Feineis, C. S., Rasmussen, V., Moegelberg, N., Brinkløv, C. F., Nielsen, A. B., Kofoed, K. S., Lauridsen, C. A., et al. (2021) · Trials · doi:10.1186/s13063-021-05207-7 · Cited by 15
Endogenous Chronic Hyperinsulinemia Does Not Increase the Production Rate of VLDL Apolipoprotein B: Proof from a Kinetic Study in Patients with Insulinoma
Duvillard, L., Florentin, E., Pont, F., Petit, J., Baillot-Rudoni, S., Penfornis, A., & Vergès, B. L. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2946 · Cited by 15
Low normal thyroid function attenuates serum alanine aminotransferase elevations in the context of metabolic syndrome and insulin resistance in white people
Dullaart, R. P. F., van den Berg, E. H., van der Klauw, M. M., & Blokzijl, H. (2014) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2014.04.016 · Cited by 14
Functional Variant Disrupts Insulin Induction of USF1
Naukkarinen, J., Nilsson, E., Koistinen, H. A., Söderlund, S., Lyssenko, V., Vaag, A. A., Poulsen, P., Groop, L., Taskinen, M., & Peltonen, L. (2009) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.108.840421 · Cited by 14
Self-citation
Adipose Tissue and Atherosclerosis
Poledne, R., Lesná, I. K., & Čejková, S. (2015) · Physiological Research · doi:10.33549/physiolres.933152 · Cited by 14
Metabolic surgery for the treatment of type 2 diabetes in patients with BMI lower than 35 kg/m2: Why caution is still needed
Halpern, B., & Mancini, M. C. (2019) · Obesity Reviews · doi:10.1111/obr.12837 · Cited by 14
Anti‐obesity effect of Melandrium firmum Rohrbach extract in 3T3‐L1 cells and high‐fat diet‐induced obese C57BL/6N mice
Kim, H., Kim, J. H., Zuo, G., & Lim, S. S. (2020) · Food Science & Nutrition · doi:10.1002/fsn3.1466 · Cited by 13
Associations of endogenous testosterone and lipid profiles in middle-aged to older Taiwanese men
Jiann, B.-P., Hsieh, J.-T., Liu, S.-P., Hsu, S. H.-J., & Wu, H.-C. (2011) · International Journal of Impotence Research · doi:10.1038/ijir.2011.5 · Cited by 14
Dietary Regulation of Hepatic Triacylglycerol Content—the Role of Eucaloric Carbohydrate Restriction with Fat or Protein Replacement
Lundsgaard, A., Bojsen-Møller, K. N., & Kiens, B. (2023) · Advances in Nutrition · doi:10.1016/j.advnut.2023.08.005 · Cited by 14
A novel, multitargeted endogenous metabolic modulator composition impacts metabolism, inflammation, and fibrosis in nonalcoholic steatohepatitis-relevant primary human cell models
Daou, N., Viader, A., Cokol, M., Nitzel, A., Chakravarthy, M. V., Afeyan, R., Tramontin, T., Marukian, S., & Hamill, M. J. (2021) · Scientific Reports · doi:10.1038/s41598-021-88913-1 · Cited by 14
Apolipoprotein A-II and adiponectin as determinants of very low-density lipoprotein apolipoprotein B-100 metabolism in nonobese men
Chan, D. C., Watts, G. F., Ooi, E. M. M., Chan, D. T., Wong, A. T. Y., & Barrett, P. H. R. (2011) · Metabolism · doi:10.1016/j.metabol.2011.03.003 · Cited by 13
Notch-ligand expression by NALT dendritic cells regulates mucosal Th1- and Th2-type responses
Fukuyama, Y., Tokuhara, D., Sekine, S., Kataoka, K., Markham, J. D., Irwin, A. R., Moon, G. H., Tokuhara, Y., Fujihashi, K., Davydova, J., et al. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.12.046 · Cited by 13
Aging and Adipose Tissue
Florido, R., Tchkonia, T., & Kirkland, J. L. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-378638-8.00005-1 · Cited by 14
Arterial hypertension, obesity and non-alcoholic fatty liver disease: is there any connection?
Kuzmіnova, N. V., Gribenyuk, O. V., Osovska, N. Y., & Knyazkova, І. І. (2016) · Arterial Hypertension · doi:10.5603/ah.2016.0025 · Cited by 13
Fatty Liver as Potential Biomarker of Atherosclerotic Damage in Familial Combined Hyperlipidemia
Mandraffino, G., Morace, C., Franzè, M. S., Nassisi, V., Sinicropi, D., Cinquegrani, M., Saitta, C., Scoglio, R., Marino, S., Belvedere, A., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10081770 · Cited by 13
PPARγ agonists—Antidiabetic drugs with a potential role in the treatment of diseases other than diabetes
Jermendy, G. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.09.017 · Cited by 13
Low-Carbohydrate Ketogenic Diet for Improvement of Glycemic Control: Mechanism of Action of Ketosis and Beneficial Effects
Das, S., Sakr, H. F., Sirasanagandla, S. R., Bima, A. I. H., & Elsamanoudy, A. Z. (2022) · Current Diabetes Reviews · doi:10.2174/1573399818666220511121629 · Cited by 13
Differential effects of volanesorsen on apoC-III, triglycerides, and pancreatitis in familial chylomicronemia syndrome diagnosed by genetic or nongenetic criteria
Tsimikas, S., Ginsberg, H. N., Alexander, V. J., Karwatowska‐Prokopczuk, E., Dibble, A., Li, L., Witztum, J. L., & Hegele, R. A. (2024) · Journal of clinical lipidology · doi:10.1016/j.jacl.2024.12.018 · Cited by 12
Quantitative relationship between liver fat content and metabolic syndrome in obese children and adolescents
Zhang, H., Yang, H., Lai, C., Xu, X., Huang, K., & Fu, J. (2015) · Clinical Endocrinology · doi:10.1111/cen.12758 · Cited by 12
Why is hypercholesterolaemia so prevalent? A view from evolutionary medicine
Laufs, U., Dent, R. E., Kostenuik, P. J., Toth, P. P., Catapano, A. L., & Chapman, M. J. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy479 · Cited by 12
The Association of Polyunsaturated Fatty Acid δ-5-Desaturase Activity with Risk Factors for Type 2 Diabetes Is Dependent on Plasma ApoB-Lipoproteins in Overweight and Obese Adults
Lamantia, V., Bissonnette, S., Provost, V., Devaux, M., Cyr, Y., Daneault, C., Rosiers, C. D., & Faraj, M. (2018) · Journal of Nutrition · doi:10.1093/jn/nxy238 · Cited by 13
Effect of Prior Exercise on Postprandial Lipemia: An Updated Meta-Analysis and Systematic Review
Pearson, R. C., Cogan, B., Garcia, S. A., & Jenkins, N. T. (2022) · International Journal of Sport Nutrition and Exercise Metabolism · doi:10.1123/ijsnem.2022-0043 · Cited by 12
Hepatic Lipoprotein Metabolism: Current and Future In Vitro Cell-Based Systems
Kiss, I., Neuwert, N., Oberle, R., Hengstschläger, M., Osmanagic-Myers, S., & Stangl, H. (2025) · Biomolecules · doi:10.3390/biom15070956 · Cited by 11
The relationship between genetic liver fat and coronary heart disease is explained by apoB-containing lipoproteins
Björnson, E., Adiels, M., Bergström, G. M. L., & Gummesson, A. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.117397 · Cited by 11
Self-citation
Plasma adiponectin is a more specific marker of fatty liver than a marker of metabolic syndrome in Japanese men
Yatsuzuka, S.-I., Shimomura, Y., Akuzawa, M., Ando, Y., Kobayashi, I., Nakano, T., Tokita, Y., Nagamine, T., Ono, H., Tanaka, A., et al. (2013) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563213487892 · Cited by 11
Kinetic Studies to Elucidate Impaired Metabolism of Triglyceride-rich Lipoproteins in Humans
Adiels, M., Mardinoğlu, A., Taskinen, M., & Borén, J. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00342 · Cited by 13
Self-citation
Five-year follow-up of waist circumference, insulin and ALT levels in familial combined hyperlipidaemia
Brouwers, M. C. G. J., van Greevenbroek, M. M. J., Vermeulen, V. M. M.-J., van Lin, J. M. J. P., Kallen, C., & de Bruin, T. W. (2007) · Clinical Science · doi:10.1042/cs20070101 · Cited by 11
Optimization of N ‐methyl‐ N ‐[ tert ‐butyldimethylsilyl]trifluoroacetamide as a derivatization agent for determining isotopic enrichment of glycerol in very‐low density lipoproteins
Adiels, M., Larsson, T. P., Sutton, P., Taskinen, M., Borén, J., & Fielding, B. A. (2010) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.4422 · Cited by 11
Self-citation
Bariatric surgery improves postprandial VLDL kinetics and restores insulin-mediated regulation of hepatic VLDL production
Yildirim, V., ter Horst, K. W., Gilijamse, P. W., van Harskamp, D., Schierbeek, H., Jansen, H., Schimmel, A. W. M., Nieuwdorp, M., Groen, A. K., Serlie, M. J. M., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.166905 · Cited by 10
Importance of Dyslipidaemia Treatment in Individuals with Type 2 Diabetes Mellitus—A Narrative Review
Strikić, D., Vujević, A., Perica, D., Leskovar, D., Paponja, K., Pećin, I., & Merćep, I. (2023) · Diabetology · doi:10.3390/diabetology4040048 · Cited by 9
Liver Fat Accumulation Is Associated With Increased Insulin Secretion Independent of Total, Visceral, and Pancreatic Fat
Sandby, K., Krarup, T., Chabanova, E., Geiker, N. R. W., & Magkos, F. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae572 · Cited by 11
Obesity phenotypes and atherogenic dyslipidemias
Choe, H. J., Almas, T., Neeland, I. J., Lim, S. K., & Després, J. (2025) · European Journal of Clinical Investigation · doi:10.1111/eci.70151 · Cited by 14
Mediating role of atherogenic lipoproteins in the relationship between liver fat and coronary artery calcification
Björnson, E., Samaras, D., Adiels, M., Kullberg, J., Bäckhed, F., Bergström, G. M. L., & Gummesson, A. (2023) · Scientific Reports · doi:10.1038/s41598-023-39390-1 · Cited by 11
Self-citation
Association of Liver Enzymes and Computed Tomography Markers of Liver Steatosis with Familial Longevity
Sala, M. L., Kroft, L. J. M., Röell, B., van der Grond, J., Slagboom, P. E., Mooijaart, S. P., Roos, A., & van Heemst, D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091085 · Cited by 9
Applications of Quantitative Systems Pharmacology (QSP) in Drug Development for NAFLD and NASH and Its Regulatory Application
Siler, S. Q. (2022) · Pharmaceutical Research · doi:10.1007/s11095-022-03295-x · Cited by 11
Association between skeletal muscle fat content and very‐low‐density lipoprotein‐apolipoprotein B‐100 transport in obesity: effect of weight loss
Chan, D. C., Gan, S. K., Wong, A. T. Y., Barrett, P. H. R., & Watts, G. F. (2014) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12311 · Cited by 11
Derangements of intravascular remodeling of lipoproteins in type 2 diabetes mellitus: Consequences for atherosclerosis development
Dallinga‐Thie, G. M., Dullaart, R. P. F., & van Tol, A. (2008) · Current Diabetes Reports · doi:10.1007/s11892-008-0012-3 · Cited by 10
Plasma adiponectin concentration is strongly associated with VLDL-TG catabolism in postmenopausal women
Lapointe, A., Tchernof, A., Lamarche, B., Piché, M., Weisnagel, J., Bergeron, J., & Lemieux, S. (2010) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.10.007 · Cited by 10
Fat-Free Mass and Skeletal Muscle Mass Gain Are Associated with Diabetes Remission after Laparoscopic Sleeve Gastrectomy in Males but Not in Females
Nguyen, N. T. K., Vo, N.-P., Huang, S., & Wang, W. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19020978 · Cited by 9
Excess Triglycerides in Very Low-Density Lipoprotein (VLDL) Estimated from VLDL-Cholesterol could be a Useful Biomarker of Metabolic Dysfunction Associated Steatotic Liver Disease in Patients with Type 2 Diabetes
Hirano, T. (2024) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.65164 · Cited by 10
ANGPTL3 as a target for treating lipid disorders in type 2 diabetes patients
Chen, J., Luo, Q., Yi, Y., Wang, J., Chen, P., Luo, F., & Fang, Z. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02352-1 · Cited by 10
Predictors of High Cardiovascular Risk Among Nonobese Patients with Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease in a Chinese Population
Ruan, S., Yuan, X., Liu, J., Zhang, Q., & Ye, X. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s441641 · Cited by 9
Machine Learning Reveals the Contribution of Lipoproteins to Liver Triglyceride Content and Inflammation
Tavaglione, F., Marafioti, G., Romeo, S., & Jamialahmadi, O. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae371 · Cited by 8
Oxidative Stress in the Metabolic Syndrome
Calhau, C., & Santos, A. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9701-0_3 · Cited by 9
A novel method for measuring intestinal and hepatic triacylglycerol kinetics
Sun, F., Stolinski, M., Shojaee‐Moradie, F., Lou, S., Ma, Y., Hovorka, R., & Umpleby, A. M. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00105.2013 · Cited by 9
Association between dietary fat intake, liver fat, and insulin sensitivity in sedentary, abdominally obese, older men
Kuk, J. L., Davidson, L. E., HUDSON, R. W., Kilpatrick, K., Bacskai, K., & Ross, R. (2008) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h07-179 · Cited by 9
AMPK-SIRT1-independent inhibition of ANGPTL3 gene expression is a potential lipid-lowering mechanism of metformin
Li, L., Burke, J., Venkatesh, S., & Sadana, P. (2019) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13138 · Cited by 10
Diabetes Mellitus and Disorder of Lipid Metabolism
Cho, H. K. (2006) · Journal of Korean Endocrine Society · doi:10.3803/jkes.2006.21.2.101 · Cited by 9
Dyslipidemia in Diabetes
Subramanian, S., & Chait, A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65798-7 · Cited by 9
Cholesterol and Inflammation at the Crossroads of Non-Alcoholic Fatty Liver Disease (NAFLD) and Atherogenesis
Lorbek, G., & Rozm, D. (2012) · InTech eBooks · doi:10.5772/27316 · Cited by 8
Associations of diet quality and food consumption with serum biomarkers for lipid and amino acid metabolism in Finnish children: the PANIC study
Laamanen, S. E., Eloranta, A., Haapala, E. A., Sallinen, T., Schwab, U., & Lakka, T. A. (2023) · European Journal of Nutrition · doi:10.1007/s00394-023-03293-8 · Cited by 11
The APOA5−1131 T>C variant enhances the association between RBP4 and hypertriglyceridemia in diabetes
Cabré, A., Lázaro, I., Girona, J., Manzanares, J. M., Marimón, F., Plana, N., Guardiola, M., Heras, M., & Masana, L. (2009) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.04.003 · Cited by 8
Postprandial Triglycerides, Flow-Mediated Dilation, and the Inflammatory Cytokine Milieu in Metabolically Healthy Obesity: A Cross-Sectional Pilot Study
Keirns, B. H., Hart, S. M., Sciarrillo, C. M., Poindexter, K. L., Clarke, S. L., & Emerson, S. R. (2021) · Obesities · doi:10.3390/obesities1010006 · Cited by 8
Olea europaea Linn. Fruit Pulp Extract Protects against Carbon Tetrachloride-induced Hepatic Damage in Mice.
Kang, H., & Koppula, S. (2014) · Europe PMC (PubMed Central) · Cited by 8
Fatty liver–based identification of two distinct hypertriglyceridemic subgroups in familial combined hyperlipidemia
Brouwers, M. C. G. J., van Greevenbroek, M. M. J., Bilderbeek-Beckers, M. A. L., Robertus-Teunissen, M. G., Kallen, C., Stehouwer, C. D. A., & de Bruin, T. W. (2007) · Metabolism · doi:10.1016/j.metabol.2007.05.023 · Cited by 8
The Role of Non-alcoholic Fatty Liver Disease in Cardiovascular Disease
Francque, S. (2014) · European Cardiology Review · doi:10.15420/ecr.2014.9.1.10 · Cited by 8
Patient-Oriented Research
Seely, E. W., & Grinspoon, S. K. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802101-9.00002-8 · Cited by 9
Serum γ‐glutamyltransferase level and metabolic syndrome in children and adolescents: Korean National Health and Nutrition Examination Survey
Park, J. M., Lee, J., Lee, D., & Lee, Y. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12716 · Cited by 8
Understanding the Impact of Added Sugar Consumption on Risk for Type 2 Diabetes
Price, C. A., & Stanhope, K. L. (2016) · Journal of the California Dental Association · doi:10.1080/19424396.2016.12221068 · Cited by 9
The Twin Cycle Hypothesis of type 2 diabetes aetiology: From concept to national NHS programme
Taylor, R. (2025) · Experimental Physiology · doi:10.1113/ep092009 · Cited by 6
Hepatic Interactions in Atherosclerotic Heart Disease
Pothineni, N. V. K., Rochlani, Y. M., Subramany, S., Kovelamudi, S., & Mehta, J. L. (2021) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2021.07.011 · Cited by 7
Association Between Serum Remnant Cholesterol Level and Metabolic Dysfunction-associated Steatotic Liver Histology
Miyake, T., Furukawa, S., Matsuura, B., Yoshida, O., Kanamoto, A., Miyazaki, M., Shiomi, A., Nakaguchi, H., Okazaki, Y., Nakamura, Y., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae597 · Cited by 7
Increased γ-glutamyltransferase and decreased total bilirubin are associated with metabolic syndrome in Korean postmenopausal women
Kim, S.-H., Lee, J., Im, J., & Hwang, H. (2010) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2010.302 · Cited by 7
Obesity and Type 2 Diabetes
(2012) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/978160805361211201010039 · Cited by 7
Hypertriglyceridemia and atherosclerosis risk
Poledne, R., & Kovář, J. (2019) · Vnitřní lékařství · doi:10.36290/vnl.2019.136 · Cited by 7
Bempedoic acid as a PPARα activator: New perspectives for hepatic steatosis treatment in a female rat experimental model
Bentanachs, R., Velázquez, A. M., Sánchez, R. M., Alegret, M., Laguna, J. C., & Roglans, N. (2022) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2022.03.001 · Cited by 7
Adjustment to dietary energy availability: from starvation to overnutrition
Alemany, M. (2012) · RSC Advances · doi:10.1039/c2ra21165c · Cited by 7
The impact of education on weight loss in overweight and obese adults.
Ostovan, M. A., Zibaeenezhad, M. J., Keshmiri, H., & Shekarforoush, S. (2013) · Europe PMC (PubMed Central) · Cited by 7
Adiponectin: Characterization, Metabolic and Cardiovascular Action
Petto, J., dos Santos, A. C. N., Motta, M. T., Filho, R. S. T., Santo, D. G. C. D. E., RIBAS, J. L. L., & Ladeia, A. M. T. (2015) · International Journal of Cardiovascular Sciences · doi:10.5935/2359-4802.20150062 · Cited by 7
Hydroxycitric acid ameliorates high-fructose-induced redox imbalance and activation of stress sensitive kinases in male Wistar rats
Sripradha, R., Sridhar, M. G., & Maithilikarpagaselvi, N. (2016) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2014-0132 · Cited by 7
Hepatic Fat in Participants With and Without Incident Diabetes in the Diabetes Prevention Program Outcome Study
Goldberg, R. B., Tripputi, M., Boyko, E. J., Budoff, M. J., Chen, Z., Clark, J. M., Dabelea, D., Edelstein, S. L., Gerszten, R. E., Horton, E. S., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab160 · Cited by 7
Postprandial triglyceride-rich lipoproteins in insulin resistance and Type 2 diabetes
Matikainen, N., & Taskinen, M. (2008) · Future Lipidology · doi:10.2217/17460875.3.5.531 · Cited by 7
Self-citation
Obesity and Type 2 Diabetes
Zhyzhneuskaya, S. V., & Taylor, R. (2017) · Endocrinology · doi:10.1007/978-3-319-47685-8_21-1 · Cited by 8
Nutrition and metabolism: non-alcoholic fatty liver disease – pathogenesis, cardiovascular risk and therapy
Watts, G. F., & Gan, S. K. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3282f41b4f · Cited by 7
Familial Combined Hyperlipidemia: Myth or Reality?
Brouwers, M. C. G. J., Klop, B., Ribalta, J., & Cabezas, M. C. (2025) · Current Atherosclerosis Reports · doi:10.1007/s11883-025-01289-9 · Cited by 6
Hypertriglyceridemia Results From an Impaired Catabolism of Triglyceride-Rich Lipoproteins in PLIN1 -Related Lipodystrophy
Vergès, B. L., Vantyghem, M., Reznik, Y., Duvillard, L., Rouland, A., Capel, É., & Vigouroux, C. (2024) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.124.320774 · Cited by 6
Lipid Metabolism in Metabolic Syndrome
Borén, J., & Adiels, M. (2013) · Springer eBooks · doi:10.1007/978-3-319-01008-3_8 · Cited by 6
Self-citation
Putting insulin resistance into context by dietary reversal of type 2 diabetes
Taylor, R. W. (2017) · The Journal of the Royal College of Physicians of Edinburgh · doi:10.4997/jrcpe.2017.216 · Cited by 6

Authors: Adiels, M., Taskinen, M.-R., Packard, C., Caslake, M. J., Soro-Paavonen, A., Westerbacka, J., Vehkavaara, S., Häkkinen, A., Olofsson, S.-O., Yki-Järvinen, H., & Borén, J.
Affiliations: University of Gothenburg (SE)
University of Helsinki (FI)
Glasgow Royal Infirmary (GB)
Sahlgrenska University Hospital (SE)
Corresponding author: Borén, J.
ORCID: Adiels, M.
Taskinen, M.-R.
Packard, C.
Häkkinen, A.
Borén, J.
Venue: Diabetologia
Publisher: Springer Science and Business Media LLC
Published: 2006-02-04
Volume: 49
Issue: 4
Pages: 755-765
ISSN: 0012-186X (ISSN-L)
1432-0428
DOI: 10.1007/s00125-005-0125-z
OpenAlex: W2051999166
Cited by: 690
References: 53
Citations by year: 2026: 15 · 2025: 26 · 2024: 29 · 2023: 21 · 2022: 35 · 2021: 29 · 2020: 40 · 2019: 31 · 2018: 27 · 2017: 27 · 2016: 37 · 2015: 41 · 2014: 41 · 2013: 45 · 2012: 38
FWCI: 26.66
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.springer.com/tdm (tdm)
Locations: Diabetologia (publishedVersion)
PubMed (publishedVersion)
Chalmers Research (Chalmers University of Technology) (submittedVersion)
Funders: Helsingin ja Uudenmaan Sairaanhoitopiiri
Göran Gustafssons Stiftelser
Hjärt-Lungfonden
Vetenskapsrådet
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords: hepatic fat content, adiponectin, apolipoprotein B, triglyceride kinetics, type 2 diabetes, insulin resistance, intra-abdominal fat, dyslipidemia
MeSH terms: Adipose Tissue, Adult, Aged, Apolipoproteins B, Diabetes Mellitus, Type 2, Fatty Liver, Humans, Lipoproteins, VLDL, Male, Middle Aged

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Overproduction of large VLDL particles is driven by increased liver fat content in man

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks